Farmakokinetikken af natalizumab hos pædiatriske MS- patienter eller hos patienter med nyre - eller leverinsufficiens er ikke blevet undersøgt.
The pharmacokinetics of natalizumab in paediatric MS patients or in patients with renal or hepatic insufficiency has not been studied.